lobbying_filings_raw: b6901ea7-c12e-4feb-9e18-bb660109c71f
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| b6901ea7-c12e-4feb-9e18-bb660109c71f | Q1 | 400497446 | EVERTZ GROUP LLC | 191844 | MYLAN INC. | 2011 | first_quarter | 2011-04-15T14:24:49.220000-04:00 | 30000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/b6901ea7-c12e-4feb-9e18-bb660109c71f/", "filing_uuid": "b6901ea7-c12e-4feb-9e18-bb660109c71f", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2011, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/b6901ea7-c12e-4feb-9e18-bb660109c71f/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Scott Evertz, Managing Member", "dt_posted": "2011-04-15T14:24:49.220000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "2440 Virginia Ave NW", "registrant_address_2": "Suite D909", "registrant_different_address": true, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20037", "registrant": {"id": 400497446, "url": "https://lda.senate.gov/api/v1/registrants/400497446/", "house_registrant_id": 41052, "name": "EVERTZ GROUP LLC", "description": "Promotion of legislation for the provision of care for those living with HIV/AIDS.", "address_1": "2440 Virginia Ave NW", "address_2": "Suite D1207", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20037", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "SCOTT EVERTZ", "contact_telephone": "+1 202-230-1770", "dt_updated": "2022-04-06T16:08:06.299445-04:00"}, "client": {"id": 191844, "url": "https://lda.senate.gov/api/v1/clients/191844/", "client_id": 24, "name": "MYLAN INC.", "general_description": "One of the leading generic and specialty pharmaceutical companies in the world.", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2009-07-23"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 50060, "prefix": null, "prefix_display": null, "first_name": "SCOTT", "nickname": null, "middle_name": null, "last_name": "EVERTZ", "suffix": null, "suffix_display": null}, "covered_position": "Spec. Asst. to the Sec. of HHS for Global AIDS ini", "new": false}], "government_entities": [{"id": 245, "name": "Office of Natl AIDS Policy"}, {"id": 1, "name": "SENATE"}, {"id": 39, "name": "State, Dept of (DOS)"}, {"id": 196, "name": "U.S. Agency for International Development (USAID)"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 41052 | DC | DC | US | US | One of the leading generic and specialty pharmaceutical companies in the world. | 0 | 0 | 2052312 | normalized_name_dc_fallback | 0.8 |